Eyebright Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
2,331
- Stock Symbol
-
688050
- Investments
-
6
- Share Price
-
$6.22
- (As of Friday Closing)
Eyebright General Information
Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
Contact Information
Website
www.ebmedical.comCorporate Office
- No. 9, Xingchang Road
- Science and Technology Park, Changping District
- Beijing, 102200
- China
Corporate Office
- No. 9, Xingchang Road
- Science and Technology Park, Changping District
- Beijing, 102200
- China
Eyebright Stock Performance
As of 13-Nov-2026, Eyebright’s stock price is $6.22. Its current market cap is $1.2B with 193M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.22 | $6.29 | $5.18 - $9.53 | $1.2B | 193M | 3.05M | $0.18 |
Eyebright Financials Summary
As of 30-Sep-2026, Eyebright has a trailing 12-month revenue of $260M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,236,351 | 1,689,629 | 2,410,345 | 2,496,372 |
| Revenue | 259,804 | 206,179 | 196,506 | 134,444 |
| EBITDA | 44,104 | 66,454 | 80,953 | 57,638 |
| Net Income | 35,350 | 37,291 | 54,129 | 42,966 |
| Total Assets | 714,064 | 555,673 | 479,030 | 431,931 |
| Total Debt | 174,519 | 82,942 | 79,324 | 55,064 |
Eyebright Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eyebright Patents
Eyebright Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021185271-A1 | Phakic intraocular lens | Inactive | 17-Mar-2020 | ||
| WO-2021147919-A1 | Medical device and manufacturing method therefor | Inactive | 20-Jan-2020 | ||
| WO-2021115310-A1 | Cross-linked hyaluronic acid gel and preparation method therefor | Inactive | 10-Dec-2019 | ||
| EP-3915518-A1 | Intraocular lens implant device and pre-loaded intraocular lens implant apparatus | Pending | 25-Jan-2019 | ||
| EP-3915518-A4 | Intraocular lens implant device and pre-loaded intraocular lens implant apparatus | Pending | 25-Jan-2019 | A61F2/167 |
Eyebright Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Eyebright Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eyebright Investments & Acquisitions (6)
Eyebright’s most recent deal was a Merger/Acquisition with Unicon Optics for . The deal was made on 11-Oct-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Unicon Optics | 11-Oct-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Tuoruimei Medical | 01-Sep-2023 | Later Stage VC | Other Pharmaceuticals and Biotechnology | ||
| TowardPi | 19-Dec-2022 | Later Stage VC | Diagnostic Equipment | ||
| Zhengli Technology | 31-Dec-2021 | Later Stage VC | Therapeutic Devices | ||
| TowardPi | 14-Dec-2021 | Early Stage VC | Diagnostic Equipment |
Eyebright ESG
Risk Overview
Risk Rating
Updated November, 30, 2025
32.44 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Healthcare
Industry
of 614
Rank
Percentile
Medical Devices
Subindustry
of 223
Rank
Percentile
Eyebright Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Unicon Optics | Fuzhou, China | 2019 | |
| Jiangsu Tianyan Pharmaceutical | Lianyungang, China | 2015 |
Eyebright FAQs
-
When was Eyebright founded?
Eyebright was founded in 2010.
-
Where is Eyebright headquartered?
Eyebright is headquartered in Beijing, China.
-
What is the size of Eyebright?
Eyebright has 2,331 total employees.
-
What industry is Eyebright in?
Eyebright’s primary industry is Diagnostic Equipment.
-
Is Eyebright a private or public company?
Eyebright is a Public company.
-
What is Eyebright’s stock symbol?
The ticker symbol for Eyebright is 688050.
-
What is the current stock price of Eyebright?
As of 13-Nov-2026 the stock price of Eyebright is $6.22.
-
What is the current market cap of Eyebright?
The current market capitalization of Eyebright is $1.2B.
-
What is Eyebright’s current revenue?
The trailing twelve month revenue for Eyebright is $260M.
-
What is Eyebright’s annual earnings per share (EPS)?
Eyebright’s EPS for 12 months was $0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
